C81-C96 - Bösartige Neubildungen des lymphatischen, blutbildenden und verwandten Gewebes, als primär festgestellt oder vermutet

Kodierinformationen - 2018

Hinweistexte, Inklusiv- und Exklusiv- Informationen mit den Texten der Elternebenen

Exklusive

Sekundäre und nicht näher bezeichnete bösartige Neubildung der Lymphknoten C77.-

Kodierhinweise

Soll das Vorliegen eines Befalls der Hirnhäute oder des Gehirns bei Neoplasien des lymphatischen, blutbildenden und verwandten Gewebes angegeben werden, ist eine zusätzliche Schlüsselnummer (C79.3) zu verwenden.
Soll das Vorliegen von Knochen(mark)herden bei malignen Lymphomen (Zustände, klassifizierbar unter C81-C88) angegeben werden, ist eine zusätzliche Schlüsselnummer (C79.5) zu verwenden.

14 untergeordnete Gruppen / Codes

In dieser Gruppe enthaltene Codes und Untergruppen.

Analyse Übersicht

Übersicht der Code Nutzung in der Marktanalyse, Patientenanalyse, G-DRG Analyse und Kalkulationsgrundlage

Mehr Details zu diesem Bereich erhalten Sie kostenfrei nach der Registrierung.

Marktanalyse

Häufigkeitsverteilung und anwendende Kliniken / Fachabteilungen

Marktanalyse der Hauptdiagnosen (ICD-10 Codes)

C81-C96 Nennungen in der Hauptdiagnose und Anzahl der einsetzenden Kliniken, Fachabteilungen pro Jahr

Das Diagramm "Nennungen als Hauptdiagnose(n) im Jahresvergleich" veranschaulicht den Trend des/der Codes in der Hauptdiagnose in den dokumentierten Krankenhausfällen.

Häufigkeitsverteilung und anwendende Kliniken / Fachabteilungen

Die folgenden Tabellen geben Aufschluss über die Einsatzhäufigkeit der Diagnosen als Hauptdiagnose (insofern eine Code Gruppe ausgewählt ist), sowie über die anwendenden Kliniken / Fachabteilungen.

Top 5 terminale Codes in dieser Gruppe

von 91 in 2006 von 90 in 2008 von 91 in 2010 von 107 in 2012 von 107 in 2013 von 103 in 2014 von 101 in 2015 von 108 in 2016
toc Nennungen Gesamt Anteil
xxx.x open_in_new
xxxxxxxxxxx xxx xxxxxxxxx xxxxxxxxxxxx-xxxxxxxxxxxx x xxxxxxxxx xxxxxx
0
0 %
C91.0 open_in_new
Lymphatische Leukämie > Akute lymphatische Leukämie [ALL]
14.839
9,24 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
xxx.x open_in_new
xxxxxxxx xxx xxxxx xxxxx xxxxxxxxxxx xxxxx xxx xxx-xxxxxxx-xxxxxxxx x x-xxxx-xxxxxxxx xxxxx xxxxx xxxxxxxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxx xxx xxxxxxxxx xxxxxxxxxxxx-xxxxxxxxxxxx x xxxxxxxxx xxxxxx
0
0 %
C83.3 open_in_new
Nicht follikuläres Lymphom > Diffuses großzelliges B-Zell-Lymphom
17.105
10,66 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxx xxx xxxxxxxxx xxxxxxxxxxxx-xxxxxxxxxxxx x xxxxxxxxx xxxxxx
0
0 %
C83.3 open_in_new
Nicht follikuläres Lymphom > Diffuses großzelliges B-Zell-Lymphom
20.322
12,22 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxx xxx xxxxx xxxxx xxxxxxxxxxx xxxxx xxx xxx-xxxxxxx-xxxxxxxx x x-xxxx-xxxxxxxx xxxxx xxxxx xxxxxxxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.0 open_in_new
Plasmozytom und bösartige Plasmazellen-Neubildungen > Multiples Myelom
21.166
11,93 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.0 open_in_new
Plasmozytom und bösartige Plasmazellen-Neubildungen > Multiples Myelom
20.798
11,55 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.0 open_in_new
Plasmozytom und bösartige Plasmazellen-Neubildungen > Multiples Myelom
20.990
11,46 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.0 open_in_new
Plasmozytom und bösartige Plasmazellen-Neubildungen > Multiples Myelom
22.399
12,31 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.0 open_in_new
Plasmozytom und bösartige Plasmazellen-Neubildungen > Multiples Myelom
23.044
12,34 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %

Top 5 Kliniken

von 1266 in 2006 von 1332 in 2008 von 1351 in 2010 von 1401 in 2012 von 1401 in 2013 von 1417 in 2014 von 1435 in 2015 von 1400 in 2016
Nennungen Listenanteil
xxxxxxx - xxxxxxxxxxxxxxxxxxx xxxxxx open_in_new
insert_chart xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
Klinikum Bremen-Mitte open_in_new
28205 Bremen | 260400015-00
2.661
1,66 %
xxxxxxxxx xxxxxx xx.xxxxx open_in_new
insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxx xxxxxxxxxxx xxxxxxx open_in_new
insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxx open_in_new
xxxxx xxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxx xxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxx open_in_new
insert_chart xxxxx xxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxx xx... open_in_new
insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxx xxx xxxxxxxx xxx xx... open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxx-xxxxx-xxxxxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx xxxxxx xxxx... open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx-xxxxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxx x. x. x. open_in_new
xxxxx xxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxx xxxxxxxxxx open_in_new
xxxxx xxxxxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new
xxxxx xxxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxx - xxxxxxxxxxxxxxxxxxx xxxxxx open_in_new
insert_chart xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
Dietrich-Bonhoeffer-Klinikum Standort... open_in_new
insert_chart 17036 Neubrandenburg | 261320010-01
2.470
1,54 %
xxxxxxxx xxx xxxxxxxxxxx xxxxxxx open_in_new
insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxx xxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxx xxx xxxxxxxx xxx xx... open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxx open_in_new
xxxxx xxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxx open_in_new
insert_chart xxxxx xxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxx xxxxx xxxxxxxxxxxxx... open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxx xxxxxxxx xxxxxx open_in_new
xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new
xxxxx xxxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxx xx... open_in_new
insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxx-xxxxx open_in_new
xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx-xxxxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxx - xxxxxxxxxxxxxxxxxxx xxxxxx open_in_new
insert_chart xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
Klinikum Chemnitz gGmbH open_in_new
insert_chart 09116 Chemnitz | 261401416-01
2.280
1,37 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxx open_in_new
xxxxx xxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxx open_in_new
insert_chart xxxxx xxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxxx - xxxxxxxxxxx xxxx... open_in_new
xxxxx xxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxx xxx xxxxxxxx xxx xx... open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxx xxxxxxxxxxx xxxxxxx open_in_new
insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxx xxxxx xxxxxxxxxxxxx... open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxx xxxxxxxx xxxxxx open_in_new
xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxx xxxxxxxxxx open_in_new
xxxxx xxxxxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxx x. x . x. open_in_new
xxxxx xxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxx xxxxxxxxxxx xxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx-xxxxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxx - xxxxxxxxxxxxxxxxxxx xxxxxx open_in_new
insert_chart xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
Klinikum Chemnitz gGmbH open_in_new
insert_chart 09116 Chemnitz | 261401416-01
2.359
1,33 %
xxxxxxxx xxx xxxxxxxxxxx xxxxxxx open_in_new
insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxx open_in_new
xxxxx xxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxx xxx xxxxxxxx xxx xx... open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxx open_in_new
insert_chart xxxxx xxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx-xxxxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxx xxxxxxxx xxxxxx open_in_new
xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxx xxxxxxxx xxxxxx-xxxx open_in_new
insert_chart xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new
xxxxx xxxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new
xxxxx xxxxxxxxx xx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxx xxxxxxxxxxx xxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxxxxx... open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxx - xxxxxxxxxxxxxxxxxxx xxxxxx open_in_new
insert_chart xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
Klinikum Chemnitz gGmbH open_in_new
insert_chart 09116 Chemnitz | 261401416-01
2.303
1,28 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxx xxxxxxxxxxx xxxxxxx open_in_new
insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxx xxx xxxxxxxx xxx xx... open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxx open_in_new
xxxxx xxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxx open_in_new
insert_chart xxxxx xxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx-xxxxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxx xxxxxxxx xxxxxx-xxxx open_in_new
insert_chart xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxx xxxxxxxx xxxxxx open_in_new
xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxx xxxxxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxx xxx xxxxxxxx xxxx... open_in_new
xxxxx xxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new
xxxxx xxxxxxxxx xx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new
xxxxx xxxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxx - xxxxxxxxxxxxxxxxxxx xxxxxx open_in_new
insert_chart xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
Klinikum Chemnitz gGmbH open_in_new
insert_chart 09116 Chemnitz | 261401416-01
2.306
1,26 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxx xxxxxxxxxxx xxxxxxx open_in_new
insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxx open_in_new
insert_chart xxxxx xxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxx open_in_new
xxxxx xxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx-xxxxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxx xxx xxxxxxxx xxx xx... open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxx xxxxxxxx xxxxxx-xxxx open_in_new
insert_chart xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxx-xxxxx open_in_new
xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new
xxxxx xxxxxxxxx xx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new
xxxxx xxxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxx xxxx open_in_new
xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx xxxxxxx ... open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxx - xxxxxxxxxxxxxxxxxxx xxxxxx open_in_new
insert_chart xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
Universitätsklinikum Würzburg open_in_new
insert_chart 97080 Würzburg | 260960079-00
2.326
1,28 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxx xxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxx xxxxxxxxxxx xxxxxxx open_in_new
insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxx open_in_new
insert_chart xxxxx xxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxx open_in_new
xxxxx xxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx-xxxxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxx xxx xxxxxxxx xxx xx... open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxx xxxxxxxx xxxxxx-xxxx open_in_new
insert_chart xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxxx - xxxxxxxxxxx xxxx... open_in_new
insert_chart xxxxx xxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new
xxxxx xxxxxxxxx xx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx xxxxxxx ... open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxx xxxxxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxx - xxxxxxxxxxxxxxxxxxx xxxxxx open_in_new
insert_chart xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
Universitätsklinikum Würzburg open_in_new
insert_chart 97080 Würzburg | 260960079-00
2.574
1,38 %
xxxxxxxx xxxxxxxx xxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxx xxxxxxxxxxx xxxxxxx open_in_new
insert_chart xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx xxxxxxx ... open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxx open_in_new
insert_chart xxxxx xxx | xxxxxxxxx-xx
0
0 %
xxxxxx xxxxxxxx xxxxxx-xxxx open_in_new
insert_chart xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxx-xxxxxxxxx open_in_new
xxxxx xxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxx open_in_new
xxxxx xxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxx open_in_new
insert_chart xxxxx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxxx open_in_new
xxxxx xxxxxxxxx xx xxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxxx xxx open_in_new
insert_chart xxxxx xxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxx-xxxxx open_in_new
xxxxx xxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxx xxx xxxxxxxx xxx xx... open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxxxxxxxxx xxxxxxxx open_in_new
insert_chart xxxxx xxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxx xxxxxxxxx - xxxxxxxxxxx xxxx... open_in_new
insert_chart xxxxx xxxxxxxxx | xxxxxxxxx-xx
0
0 %
xxxxxxxxxxxxx xxxxxxxxxxx xxxx open_in_new
xxxxx xxxx | xxxxxxxxx-xx
0
0 %

Patientenanalyse

Abrechnungsanzahl, Verteilung nach Geschlecht und Alter, sowie der Liegedauer für Hauptdiagnosen (ICD-10)

Patientenanalyse nach Hauptdiagnosen im vollstationären Bereich (ICD-10 Codes)

C81-C96 Fälle mit diesem Diagnosecode (ICD-10 Code) in der Haupdiagnose pro Jahr in abgerechneten Krankenhausfällen

Das Diagramm "Fälle im Jahresvergleich" veranschaulicht den Trend des/der Codes in der Hauptdiagnose der vollstationären Krankenhausfälle.

C81-C96 Anzahl der abgerechnete Krankenhausfälle, mit den verbundenen Diagnosen (ICD-10 Codes) als Hauptdiagnose, aufgeteilt nach Alter und Geschlecht.

Das Diagramm "Verteilung nach Alter und Geschlecht" zeigt die Anzahl der Fälle nach betroffenen Altersgruppen, angereichert um die Verteilung männlicher und weiblicher Patienten mit dieser(n) Hauptdiagnose(n).

C81-C96 Durchschnittliche Verweildauer von Patienten, mit diesem Code in der Hauptdiagnose, aufgeteilt nach Alter und Geschlecht.

Das Diagramm "Durchschnittliche Aufenthaltsdauer in Tagen" gibt Aufschluss über die durchschnittliche Verweildauer in Tagen der stationär behandelten Patienten, aufgeteilt nach Altersgruppe und Geschlecht.

Häufigkeitsverteilung

Folgende Tabelle zeigt die am häufigsten in der Hauptdiagnose verwendeten, untergeordneten Diagnosecodes.

Top 5 terminale Codes in dieser Gruppe

von 78 in 2006 von 78 in 2007 von 78 in 2008 von 76 in 2009 von 79 in 2010 von 94 in 2011 von 93 in 2012 von 94 in 2013 von 93 in 2014 von 94 in 2015 von 94 in 2016 von 0 in 2017
toc Nennungen Listenanteil
xxx.x open_in_new
xxxxxxxxxxx xxx xxxxxxxxx xxxxxxxxxxxx-xxxxxxxxxxxx x xxxxxxxxx xxxxxx
0
0 %
C91.0 open_in_new
Lymphatische Leukämie > Akute lymphatische Leukämie [ALL]
14.822
10,49 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxx xxx xxxxxxxxx xxxxxxxxxxxx-xxxxxxxxxxxx x xxxxxxxxx xxxxxx
0
0 %
C91.0 open_in_new
Lymphatische Leukämie > Akute lymphatische Leukämie [ALL]
14.525
10,69 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxx xxx xxxxxxxxx xxxxxxxxxxxx-xxxxxxxxxxxx x xxxxxxxxx xxxxxx
0
0 %
C83.3 open_in_new
Nicht follikuläres Lymphom > Diffuses großzelliges B-Zell-Lymphom
15.693
11,74 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxx xxx xxxxxxxxx xxxxxxxxxxxx-xxxxxxxxxxxx x xxxxxxxxx xxxxxx
0
0 %
C83.3 open_in_new
Nicht follikuläres Lymphom > Diffuses großzelliges B-Zell-Lymphom
17.041
12,8 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxx xxx xxxxxxxxx xxxxxxxxxxxx-xxxxxxxxxxxx x xxxxxxxxx xxxxxx
0
0 %
C83.3 open_in_new
Nicht follikuläres Lymphom > Diffuses großzelliges B-Zell-Lymphom
18.620
13,76 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.0 open_in_new
Plasmozytom und bösartige Plasmazellen-Neubildungen > Multiples Myelom
18.337
13,37 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.0 open_in_new
Plasmozytom und bösartige Plasmazellen-Neubildungen > Multiples Myelom
18.454
13,25 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.0 open_in_new
Plasmozytom und bösartige Plasmazellen-Neubildungen > Multiples Myelom
18.343
13,02 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.0 open_in_new
Plasmozytom und bösartige Plasmazellen-Neubildungen > Multiples Myelom
18.693
13,06 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.0 open_in_new
Plasmozytom und bösartige Plasmazellen-Neubildungen > Multiples Myelom
19.610
13,88 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.0 open_in_new
Plasmozytom und bösartige Plasmazellen-Neubildungen > Multiples Myelom
20.479
14,06 %
xxx.x open_in_new
xxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx
0
0 %
xxx.x open_in_new
xxxxxxxxxxxx xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx
0
0 %

G-DRG Analyse

Echtzuordnungen zu Fallpauschalen (DRG) aller Krankenhäuser

DRG Analyse der Diagnose (ICD-10 Codes) in der Hauptdiagnose

C81-C96 Verteilung und Anzahl der zuordnungsrelevanten Fallpauschalen (DRG) zur Hauptdiagnose (ICD-10 Codes) pro Jahr

Das Diagramm "Top 5 DRG pro Jahr" veranschaulicht die Echt-Zuordnung zu den Fallpauschalen unter Verwendung des ICD Codes in der Hauptdiagnose. Ist eine Code Gruppe ausgewählt sind alle untergeordneten Codes inkludiert.

Häufigkeitsverteilung

Die folgende Tabelle gibt Aufschluss über die real abgerechneten Fallpauschalen (G-DRG), unter Verwendung dieses/dieser ICD-Codes (insofern eine Code Gruppe ausgewählt ist) in der Hauptdiagnose. Die Sortierung erfolgt absteigend nach Häufigkeit. Hinweis: Zuordnung Normallieger in der Hauptabteilung!

Top 5 DRG

von 85 in 2016 von 86 in 2015 von 81 in 2014
toc Fälle Gesamt Anteil
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxxx xx. xxxxxxx xx. xxxxxxx. xxxxxxxx.x xx. xxxxxxxxx xxxxxxx. xxxxxxxxx xx. xxx. xxxx. xxx xxx xxxxx. xxxxxxxx xx. xxxxxxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxxxxxx xxxxx x xx xxxxxx xx. xxxx. xxxxxxx xx. xx. xxxx. xxxxxxxxxxxxx
0
0 %
R61H open_in_new
Lymphom und nicht akute Leukämie, oh. Sepsis, oh. kompliz. Konstellation, oh. Agranulozytose, oh. Portimpl., oh. Komplexbeh. MRE, oh. kompl. Diagnostik bei Leukämie, oh. äuß. schw. CC, oh. kompl. Diagnose, oh. Knochenaffektionen, oh. Knochenmarkbiopsie
23.394
18,68 %
xxxx open_in_new
xxxxxxxxxxxxxx xxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxxxxxxxx xxxxx x xx xxxxx
0
0 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxx xxx xxxxxxxxx. xx. xxxxxxxxxxx. xx. xxxxxxxxxx. xxx xx. xxxxx. xxxx. x. xxxx.x xxx. x xx x.x xxx xxxxxx. xxxxxxx. xx. xxx xxx. xxxx. xx xx. xxxxxxxxx-xxxxxxx xx. xxxxxxxxxxxxx xx. xxxxx. xxxx. x. xxxx.x xx. xxxxxxxxx xx
0
0 %
xxxx open_in_new
xxxxx xxxxxxxxxx xxxxxxxx xxxx xxxxxxxxxxxxxx xxxx xxxxxxxx xxxx xxxxxxx xxxxxxx xxx xxxx xxxxxxxxxxxxxxxxx xxx xxxxxxxxxxxxxxxx xxxxxxxx
0
0 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxxx xx. xxxxxxx xx. xxxxxxx. xxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxx xx. xxxxxxxx.x xx. xxxxxxxxxx. xxxx xx. xxxxx. xxxxxxxxxx xxx xxxxxxxxx xx. xxx. xxxx. xxx xx. xxxxx. xxxxxxxxx xx. xxxxxxxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxxxxx
0
0 %
R61G open_in_new
Lymphom und nicht akute Leukämie, oh. Sepsis, oh. kompliz. Konstell., oh. bestimmte kompliz. Faktoren, oh. äuß. schw. CC, mit kompl. Diagnose od. Knochenaffektionen od. Knochenmarkbiopsie, Alter > 15 Jahre, oh. best. Lymphom od. oh. best. Chemotherapie
22.036
18,16 %
xxxx open_in_new
xxxxxxxxxxxxxx xxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxxxxxxxx xxxxx x xx xxxxx
0
0 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxx xxx xxxxxxxxx. xx. xxxxxxxxxxx. xx. xxxxxxxxxx. xxx xx. xxxxx. xxxx. x. xxxx.x xxx. x xx x.x xxx xxxxxx. xxxxxxx. xx. xxx xxx. xxxx. xx xx. xxxxxxxxx-xxxxxxx xx. xxxxxxxxxxxxx xx. xxxxx. xxxx. x. xxxx.x xx. xxxxxxxxx xx
0
0 %
xxxx open_in_new
xxxxxx xxxxx xxxxxxxx xxxx xxxxxxxx xxxx xxxxxxx xxxx xxxxxxxxxxxxxxx xxxx xxxxxxxxxxxxxxxxx xxxx xxxxxxx xxxxxxx xx
0
0 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxxx xx. xxxxxxx xx. xxxxxxx. xxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxx xx. xxxxxxxx.x xx. xxxxxxxxxx. xxxx xx. xxxxx. xxxxxxxxxx xxx xxxxxxxxx xx. xxx. xxxx. xxx xx. xxxxx. xxxxxxxxx xx. xxxxxxxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxxxxx
0
0 %
R61G open_in_new
Lymphom und nicht akute Leukämie, oh. Sepsis, oh. kompliz. Konstell., oh. bestimmte kompliz. Faktoren, oh. äuß. schw. CC, mit kompl. Diagnose od. Knochenaffektionen od. Knochenmarkbiopsie, Alter > 15 Jahre, oh. best. Lymphom od. oh. best. Chemotherapie
23.241
18,99 %
xxxx open_in_new
xxxxxxxxxxxxxx xxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxxxxxxxx xxxxx x xx xxxxx
0
0 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxx xxx xxxxxxxxx. xx. xxxxxxxxxxx. xx. xxxxxxxxxx. xxx xx. xxxxx. xxxx. x. xxxx.x xxx. x xx x.x xxx xxxxxx. xxxxxxx. xx. xxx xxx. xxxx. xx xx. xxxxxxxxx-xxxxxxx xx. xxxxxxxxxxxxx xx. xxxxx. xxxx. x. xxxx.x xx. xxxxxxxxx xx
0
0 %
xxxx open_in_new
xxxxxxxxxxxxxx xxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxxxxxxxx xxxxx x xx xxxxx
0
0 %

Top 5 terminale Codes in dieser Gruppe

von 105 in 2016 von 104 in 2015 von 104 in 2014
toc Fälle Gesamt Anteil
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.00 open_in_new
Multiples Myelom > Ohne Angabe einer kompletten Remission
17.042
13,61 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.00 open_in_new
Multiples Myelom > Ohne Angabe einer kompletten Remission
16.486
13,58 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.00 open_in_new
Multiples Myelom > Ohne Angabe einer kompletten Remission
15.697
12,82 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %

DRG Analyse der Diagnose (ICD-10 Codes) in der Nebendiagnose

C81-C96 Verteilung und Anzahl der zuordnungsrelevanten Fallpauschalen (DRG) zur Nebendiagnose (ICD-10 Codes) pro Jahr

Das Diagramm "Top 5 DRG pro Jahr" veranschaulicht die Echt-Zuordnung zu den Fallpauschalen unter Verwendung des ICD Codes in der Nebendiagnose. Ist eine Code Gruppe ausgewählt sind alle untergeordneten Codes inkludiert.

Häufigkeitsverteilung

Die folgende Tabelle gibt Aufschluss über die real abgerechneten Fallpauschalen (G-DRG), unter Verwendung dieses/dieser ICD-Codes (insofern eine Code Gruppe ausgewählt ist) in der Nebendiagnose. Die Sortierung erfolgt absteigend nach Häufigkeit. Hinweis: Zuordnung Normallieger in der Hauptabteilung!

Top 5 DRG

von 638 in 2016 von 613 in 2015 von 595 in 2014
toc Codierungen Gesamt Anteil
xxxx open_in_new
xxxxxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxx xxxxxxxxxxxx xxxxxxxxxxxx xxx xxxxxxxxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx
0
0 %
E79D open_in_new
Infektionen und Entzündungen der Atmungsorgane ohne komplexe Diagnose, ohne äußerst schwere CC oder ein Belegungstag, außer bei Para- / Tetraplegie, ohne bestimmte mäßig aufwendige Behandlung, Alter > 0 Jahre
2.844
3,98 %
xxxx open_in_new
xxxxxxxxxxxxxx xxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxxxxxxxx xxxxx x xx xxxxx
0
0 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxxx xx. xxxxxxx xx. xxxxxxx. xxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxx xx. xxxxxxxx.x xx. xxxxxxxxxx. xxxx xx. xxxxx. xxxxxxxxxx xxx xxxxxxxxx xx. xxx. xxxx. xxx xx. xxxxx. xxxxxxxxx xx. xxxxxxxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxxxxx
0
0 %
xxxx open_in_new
xxxxxxxxxxxxxxxx xxx xxxxxx xxxx xxxxxxx xxxxxxx xx xxxx xxxx xxxxxxxx xxxx xxxxxxxxxxxxxx xxxxxxxxx xxxx xxxxxxxxxxxxxx xxxxxxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx xxxxxxxxxxxx
0
0 %
xxxx open_in_new
xxxxxxxxxxx xxx xxxxxxxxxxxx xxx xxxxxxxxxxxxx xxxx xxxxxxxx xxxxxxxxx xxxx xxxxxxx xxxxxxx xx xxxx xxx xxxxxxxxxxxxx xxxxx x x xxxxxx xxxxx xxx xxxx- x xxxxxxxxxxxx xxxx xxxxxxxxxxxxxxxxx xxx xxxxxxxxxxxxxxxx xxxxxxxx
0
0 %
G67A open_in_new
Ösophagitis, Gastroenteritis, gastrointestinale Blutung, Ulkuserkrankung und verschiedene Erkrankungen der Verdauungsorgane mit bestimmten komplizierenden Faktoren
2.803
4,02 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxxx xx. xxxxxxx xx. xxxxxxx. xxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxx xx. xxxxxxxx.x xx. xxxxxxxxxx. xxxx xx. xxxxx. xxxxxxxxxx xxx xxxxxxxxx xx. xxx. xxxx. xxx xx. xxxxx. xxxxxxxxx xx. xxxxxxxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxxxxx
0
0 %
xxxx open_in_new
xxxxxxxxxxxxxx xxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxxxxxxxx xxxxx x xx xxxxx
0
0 %
xxxx open_in_new
xxxxxxxxxxxxxxxx xxx xxxxxx xxx xxx. xxxx. xxx xxx xxxxxxx xxxx xxxxxxx. xxxx. xxxx xxx xxxx. xxxxxxxx. xxx. xxxx xxxx xxxxxxx. xxxxxxxxxxxxxx xxxx xxxx. xxxxxxxx. xxx.x xxxx xxx x xxxxxxxxxxxx xxx xxxx. xxxxxx xxxxxxxxxxxxxx xxx xxx. xxxx. xx
0
0 %
xxxx open_in_new
xxxxxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxx xxxxxxxxxxxx xxxxxxxxxxxx xxx xxxxxxxxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx
0
0 %
E77I open_in_new
Infektionen und Entzündungen der Atmungsorgane ohne komplexe Diagnose, ohne äußerst schwere CC oder ein Belegungstag, Alter > 0 Jahre, außer bei Para- / Tetraplegie, ohne Komplexbehandlung bei multiresistenten Erregern
2.415
3,58 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxxx xx. xxxxxxx xx. xxxxxxx. xxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxx xx. xxxxxxxx.x xx. xxxxxxxxxx. xxxx xx. xxxxx. xxxxxxxxxx xxx xxxxxxxxx xx. xxx. xxxx. xxx xx. xxxxx. xxxxxxxxx xx. xxxxxxxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxxxxx
0
0 %
xxxx open_in_new
xxxxxxxxxxxxxx xxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxxxxxxxx xxxxx x xx xxxxx
0
0 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxxx xx. xxxxxxx xx. xxxxxxx. xxxxxxxx.x xx. xxxxxxxxx xxxxxxx. xxxxxxxxx xx. xxx. xxxx. xxx xxx xxxxx. xxxxxxxx xx. xxxxxxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxxxxxx xxxxx x xx xxxxxx xx. xxxx. xxxxxxx xx. xx. xxxx. xxxxxxxxxxxxx
0
0 %

Top 5 terminale Codes in dieser Gruppe

von 95 in 2016 von 90 in 2015 von 95 in 2014
toc Fälle Gesamt Anteil
xxx.xx open_in_new
xxxxxxxxx xxxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
C91.10 open_in_new
Chronische lymphatische Leukämie vom B-Zell-Typ [CLL] > Ohne Angabe einer kompletten Remission
12.282
17,2 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.x open_in_new
xxxxxxxx xxx xxxxx xxxxx xxxxxxxxxxx xxxxx xxx xxx-xxxxxxx-xxxxxxxx x x-xxxx-xxxxxxxx xxxxx xxxxx xxxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxxxxxx xxxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
C91.10 open_in_new
Chronische lymphatische Leukämie vom B-Zell-Typ [CLL] > Ohne Angabe einer kompletten Remission
12.240
17,54 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.x open_in_new
xxxxxxxx xxx xxxxx xxxxx xxxxxxxxxxx xxxxx xxx xxx-xxxxxxx-xxxxxxxx x x-xxxx-xxxxxxxx xxxxx xxxxx xxxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxxxxxx xxxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
C91.10 open_in_new
Chronische lymphatische Leukämie vom B-Zell-Typ [CLL] > Ohne Angabe einer kompletten Remission
11.801
17,48 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.x open_in_new
xxxxxxxx xxx xxxxx xxxxx xxxxxxxxxxx xxxxx xxx xxx-xxxxxxx-xxxxxxxx x x-xxxx-xxxxxxxx xxxxx xxxxx xxxxxxxxxx
0
0 %

Kalkulationsgrundlage

Echtzuordnungen zu Fallpauschalen (DRG) Kalkulationskrankenhäuser

DRG Analyse der Diagnose (ICD-10 Codes) in der Hauptdiagnose

C81-C96 Verteilung und Anzahl der zuordnungsrelevanten Fallpauschalen (DRG) zur Hauptdiagnose (ICD-10 Codes) pro Jahr, in den Kalkulationskrankenhäusern.

Das Diagramm "Top 5 DRG pro Jahr Kalkulation" veranschaulicht die Echt-Zuordnung zu den Fallpauschalen unter Verwendung des ICD Codes in der Hauptdiagnose. Ist eine Code Gruppe ausgewählt sind alle untergeordneten Codes inkludiert.

Häufigkeitsverteilung

Die folgende Tabelle gibt Aufschluss über die real abgerechneten Fallpauschalen (G-DRG), unter Verwendung dieses/dieser ICD-Codes (insofern eine Code Gruppe ausgewählt ist) in der Hauptdiagnose. Die Sortierung erfolgt absteigend nach Häufigkeit. Hinweis: Zuordnung Normallieger in der Hauptabteilung!

Top 5 DRG

von 65 in 2016 von 63 in 2015 von 63 in 2014
toc Fälle Gesamt Anteil
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxxx xx. xxxxxxx xx. xxxxxxx. xxxxxxxx.x xx. xxxxxxxxx xxxxxxx. xxxxxxxxx xx. xxx. xxxx. xxx xxx xxxxx. xxxxxxxx xx. xxxxxxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxxxxxx xxxxx x xx xxxxxx xx. xxxx. xxxxxxx xx. xx. xxxx. xxxxxxxxxxxxx
0
0 %
R61H open_in_new
Lymphom und nicht akute Leukämie, oh. Sepsis, oh. kompliz. Konstellation, oh. Agranulozytose, oh. Portimpl., oh. Komplexbeh. MRE, oh. kompl. Diagnostik bei Leukämie, oh. äuß. schw. CC, oh. kompl. Diagnose, oh. Knochenaffektionen, oh. Knochenmarkbiopsie
6.157
17,08 %
xxxx open_in_new
xxxxxxxxxxxxxx xxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxxxxxxxx xxxxx x xx xxxxx
0
0 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxx xxx xxxxxxxxx. xx. xxxxxxxxxxx. xx. xxxxxxxxxx. xxx xx. xxxxx. xxxx. x. xxxx.x xxx. x xx x.x xxx xxxxxx. xxxxxxx. xx. xxx xxx. xxxx. xx xx. xxxxxxxxx-xxxxxxx xx. xxxxxxxxxxxxx xx. xxxxx. xxxx. x. xxxx.x xx. xxxxxxxxx xx
0
0 %
xxxx open_in_new
xxxxxx xxxxx xxxxxxxx xxxx xxxxxxxx xxxx xxxxxxx xxxx xxxxxxxxxxxxxxx xxxx xxxxxxxxxxxxxxxxx xxxx xxxxxxx xxxxxxx xx
0
0 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxxx xx. xxxxxxx xx. xxxxxxx. xxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxx xx. xxxxxxxx.x xx. xxxxxxxxxx. xxxx xx. xxxxx. xxxxxxxxxx xxx xxxxxxxxx xx. xxx. xxxx. xxx xx. xxxxx. xxxxxxxxx xx. xxxxxxxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxxxxx
0
0 %
R61G open_in_new
Lymphom und nicht akute Leukämie, oh. Sepsis, oh. kompliz. Konstell., oh. bestimmte kompliz. Faktoren, oh. äuß. schw. CC, mit kompl. Diagnose od. Knochenaffektionen od. Knochenmarkbiopsie, Alter > 15 Jahre, oh. best. Lymphom od. oh. best. Chemotherapie
7.057
20,82 %
xxxx open_in_new
xxxxxxxxxxxxxx xxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxxxxxxxx xxxxx x xx xxxxx
0
0 %
xxxx open_in_new
xxxxxx xxxxx xxxxxxxx xxxx xxxxxxxx xxxx xxxxxxx xxxx xxxxxxxxxxxxxxx xxxx xxxxxxxxxxxxxxxxx xxxx xxxxxxx xxxxxxx xx
0
0 %
xxxx open_in_new
xxxxxxxxxxxxxx xxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxxxxxxxx xxxxx x xx xxxxx
0
0 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxxx xx. xxxxxxx xx. xxxxxxx. xxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxx xx. xxxxxxxx.x xx. xxxxxxxxxx. xxxx xx. xxxxx. xxxxxxxxxx xxx xxxxxxxxx xx. xxx. xxxx. xxx xx. xxxxx. xxxxxxxxx xx. xxxxxxxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxxxxx
0
0 %
R61G open_in_new
Lymphom und nicht akute Leukämie, oh. Sepsis, oh. kompliz. Konstell., oh. bestimmte kompliz. Faktoren, oh. äuß. schw. CC, mit kompl. Diagnose od. Knochenaffektionen od. Knochenmarkbiopsie, Alter > 15 Jahre, oh. best. Lymphom od. oh. best. Chemotherapie
7.539
20,68 %
xxxx open_in_new
xxxxxxxxxxxxxx xxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxxxxxxxx xxxxx x xx xxxxx
0
0 %
xxxx open_in_new
xxxxxx xxxxx xxxxxxxx xxxx xxxxxxxx xxxx xxxxxxx xxxx xxxxxxxxxxxxxxx xxxx xxxxxxxxxxxxxxxxx xxxx xxxxxxx xxxxxxx xx
0
0 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxx xxx xxxxxxxxx. xx. xxxxxxxxxxx. xx. xxxxxxxxxx. xxx xx. xxxxx. xxxx. x. xxxx.x xxx. x xx x.x xxx xxxxxx. xxxxxxx. xx. xxx xxx. xxxx. xx xx. xxxxxxxxx-xxxxxxx xx. xxxxxxxxxxxxx xx. xxxxx. xxxx. x. xxxx.x xx. xxxxxxxxx xx
0
0 %

Top 5 terminale Codes in dieser Gruppe

von 89 in 2016 von 91 in 2015 von 88 in 2014
toc Fälle Gesamt Anteil
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.00 open_in_new
Multiples Myelom > Ohne Angabe einer kompletten Remission
5.369
14,89 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.00 open_in_new
Multiples Myelom > Ohne Angabe einer kompletten Remission
4.901
14,46 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
C90.00 open_in_new
Multiples Myelom > Ohne Angabe einer kompletten Remission
4.976
13,65 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxx x-xxxx-xxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %

DRG Analyse der Diagnose (ICD-10 Codes) in der Nebendiagnose

C81-C96 Verteilung und Anzahl der zuordnungsrelevanten Fallpauschalen (DRG) zur Nebendiagnose (ICD-10 Codes) pro Jahr

Das Diagramm "Top 5 DRG pro Jahr Kalkulation" veranschaulicht die Echt-Zuordnung zu den Fallpauschalen unter Verwendung des ICD Codes in der Nebendiagnose. Ist eine Code Gruppe ausgewählt sind alle untergeordneten Codes inkludiert.

Häufigkeitsverteilung

Die folgende Tabelle gibt Aufschluss über die real abgerechneten Fallpauschalen (G-DRG), unter Verwendung dieses/dieser ICD-Codes (insofern eine Code Gruppe ausgewählt ist) in der Nebendiagnose. Die Sortierung erfolgt absteigend nach Häufigkeit. Hinweis: Zuordnung Normallieger in der Hauptabteilung!

Top 5 DRG

von 288 in 2016 von 266 in 2015 von 283 in 2014
toc Codierungen Gesamt Anteil
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxxx xx. xxxxxxx xx. xxxxxxx. xxxxxxxx.x xx. xxxxxxxxx xxxxxxx. xxxxxxxxx xx. xxx. xxxx. xxx xxx xxxxx. xxxxxxxx xx. xxxxxxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxxxxxx xxxxx x xx xxxxxx xx. xxxx. xxxxxxx xx. xx. xxxx. xxxxxxxxxxxxx
0
0 %
G67A open_in_new
Ösophagitis, Gastroenteritis, gastrointestinale Blutung, Ulkuserkrankung und verschiedene Erkrankungen der Verdauungsorgane mit bestimmten komplizierenden Faktoren
578
4,7 %
xxxx open_in_new
xxxxxxxxxxx xxx xxxxxxxxxxxx xxx xxxxxxxxxxxxx xxxx xxxxxxxx xxxxxxxxx xxxx xxxxxxx xxxxxxx xx xxxx xxx xxxxxxxxxxxxx xxxxx xxx xxxx- x xxxxxxxxxxxx xxxx xxxxxxxxx xxxxx xxxxxxxxxx xxxxxxxxxxx xxxxx x x xxxxx
0
0 %
xxxx open_in_new
xxxxxx xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxx xxxxxxxxx xxxxxxxxx xxxxx x xx xxxxxx xxx xxxxxxxxxxxx xxxx xxxx xxxxxxxx xxxxxxxx
0
0 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxxx xxx xxxxxx xxxx xxxxxxxxxxxxxxx xxxxxxxxxxxxx xxxx xxx xxxxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx xxxx xxxxxxxxxxxxxxxxx xxx xxx. xxxx. xxx xxxxx x xx xxxxxx xxx xxxxxxxxx. xxxxxxxxxxxxx xxxx xxxxxxxxxx xx
0
0 %
xxxx open_in_new
xxxxxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxx xxxxxxxxxxxx xxxxxxxxxxxx xxx xxxxxxxxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx
0
0 %
E79D open_in_new
Infektionen und Entzündungen der Atmungsorgane ohne komplexe Diagnose, ohne äußerst schwere CC oder ein Belegungstag, außer bei Para- / Tetraplegie, ohne bestimmte mäßig aufwendige Behandlung, Alter > 0 Jahre
556
4,76 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxxx xx. xxxxxxx xx. xxxxxxx. xxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxx xx. xxxxxxxx.x xx. xxxxxxxxxx. xxxx xx. xxxxx. xxxxxxxxxx xxx xxxxxxxxx xx. xxx. xxxx. xxx xx. xxxxx. xxxxxxxxx xx. xxxxxxxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxxxxx
0
0 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxxx xx. xxxxxxx xx. xxxxxxx. xxxxxxxx.x xx. xxxxxxxxx xxxxxxx. xxxxxxxxx xx. xxx. xxxx. xxx xxx xxxxx. xxxxxxxx xx. xxxxxxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxxxxxx xxxxx x xx xxxxxx xx. xxxx. xxxxxxx xx. xx. xxxx. xxxxxxxxxxxxx
0
0 %
xxxx open_in_new
xxxxxx xxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxx xxx xxxxxxxxx xxxxxxxxx xxxxx x xx xxxxxx xxx xxxxxxxxxxxx xxxx xxxx xxxxxxxx xxxxxxxx
0
0 %
xxxx open_in_new
xxxxxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxx xxxxxxxxxxxx xxxxxxxxxxxx xxx xxxxxxxxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx
0
0 %
R61H open_in_new
Lymphom und nicht akute Leukämie, oh. Sepsis, oh. kompliz. Konstellation, oh. Agranulozytose, oh. Portimpl., oh. Komplexbeh. MRE, oh. kompl. Diagnostik bei Leukämie, oh. äuß. schw. CC, oh. kompl. Diagnose, oh. Knochenaffektionen, oh. Knochenmarkbiopsie
500
4,22 %
xxxx open_in_new
xxxxxxx xxx xxxxx xxxxx xxxxxxxxx xx. xxxxxxx xx. xxxxxxx. xxxxxxxx.x xx. xxxxxxxxx xxxxxxx. xxxxxxxxx xx. xxx. xxxx. xxx xxx xxxxx. xxxxxxxx xx. xxxxxxxxxxxxxxxxxx xx. xxxxxxxxxxxxxxxxxxx xxxxx x xx xxxxxx xx. xxxx. xxxxxxx xx. xx. xxxx. xxxxxxxxxxxxx
0
0 %
xxxx open_in_new
xxxxxxxxxxx xxx xxxxxxxxxxxx xxx xxxxxxxxxxxxx xxxx xxxxxxxx xxxxxxxxx xxxx xxxxxxx xxxxxxx xx xxxx xxx xxxxxxxxxxxxx xxxxx x x xxxxxx xxxxx xxx xxxx- x xxxxxxxxxxxx xxxx xxxxxxxxxxxxxxxxx xxx xxxxxxxxxxxxxxxx xxxxxxxx
0
0 %
xxxx open_in_new
xxxxxxxxxxxx xxx xxxxxxxxxxxxxxxxxxxxx xxxxxxxx xxx xxxxxxxxxxxx xxx xxxxxxxxxxxxxxxxxxx xxx xxxxxxxxx xxxxxxxx xxxx xxxxxxx xxxxxxxx xxxx xxxxxxxx xxx xxxx xxxxxxxxxxxxxxx xxxx xxxxxxxxxxxxxxxxxxx xxxx xxxxx x xx xxxxx
0
0 %

Top 5 terminale Codes in dieser Gruppe

von 58 in 2016 von 57 in 2015 von 62 in 2014
toc Fälle Gesamt Anteil
xxx.xx open_in_new
xxxxxxxxx xxxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
C91.10 open_in_new
Chronische lymphatische Leukämie vom B-Zell-Typ [CLL] > Ohne Angabe einer kompletten Remission
1.998
16,25 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxxxxxx xxxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
C91.10 open_in_new
Chronische lymphatische Leukämie vom B-Zell-Typ [CLL] > Ohne Angabe einer kompletten Remission
1.896
16,23 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxxxxxx xxxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
C91.10 open_in_new
Chronische lymphatische Leukämie vom B-Zell-Typ [CLL] > Ohne Angabe einer kompletten Remission
1.930
16,3 %
xxx.x open_in_new
xxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxxxxxxxxxx x-xxxx-xxxxxxx
0
0 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
xxx.xx open_in_new
xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx x xxxx xxxxxx xxxxx xxxxxxxxxx xxxxxxxxx
0
0 %
expand_less

Das sehen Sie nach der Registrierung help

Kostenlose Basisversion Premiumversion
Basis Account Basis Account Leistungserbringer
  • DRG Kataloge
  • NUB Börse **
  • Produkte **
  • G-DRG Analyse *
  • Marktanalyse *
  • Patientenanalyse *
  • Geo Analyse
  • Klinik Guide
  • DRG Kataloge
  • NUB Börse
  • Produkte
  • G-DRG Analyse
  • Marktanalyse *
  • Patientenanalyse *
  • Geo Analyse
  • Klinik Guide
  • DRG Kataloge
  • NUB Börse
  • Produkte
  • G-DRG Analyse
  • Marktanalyse
  • Patientenanalyse
  • Geo Analyse
  • Klinik Guide
* Einsicht der Demoversion    ** ohne Veröffentlichung
Hinweis: Zum Schutz unserer Kunden sind NUB- und Produktdetailansichten nur durch verifizierte Leistungserbringer einsehbar!

Noch keinen Login? Jetzt Registrieren

Benötigen Sie Hilfe oder haben Sie Fragen?

Unser Expertenteam steht Ihnen gerne auch für die folgenden Themengebiete zur Verfügung

DRG Schulungen
Wir bieten Ihnen individuelle Team- und Einzelschulungen rund um das Thema G-DRG an. Auf Wunsch mit Portfoliobezug und/oder mit dem Baustein „Medizincontrolling".
Strategieberatung
Planen Sie zum richtigen Zeitpunkt die notwendigen Schritte. Ob und wie die Erstattung medizinischer Verfahren (Produkte) über den GKV Leistungskatalog erfolgt, bedarf grundlegender Systemkenntnisse.
Antragswesen
Die Erstellung von Anträgen zu NUB, OPS oder auch zur DRG Systementwicklung gehört zu unseren Kernkompetenzen. Gerne beraten wir Sie und begleiten Sie auf Ihrem Weg.
Analysen
Wir erstellen umfangreiche sowie individuelle Markt-, Trend- und Erstattungsanalysen rund um Ihr Verfahren (Produkt). Welche Daten können erhoben werden und welche Aussage treffen diese?
Um Ihnen den bestmöglichen Service zu bieten, speichern wir Informationen über Ihren Besuch in Cookies (Deutsch: Kekse). Durch die Nutzung unserer Webseite erklären Sie sich mit der Verwendung von Cookies einverstanden.
Mehr zum Datenschutz
Einverstanden